ask="4.75"
ask_size="100"
average_daily_volume="217640"
bid="2.19"
bid_size="100"
book_value="0.74"
change="+0.11"
change_from_200_day_moving_average="1.17"
change_from_50_day_moving_average="0.69"
change_from_52_week_high="-0.67"
change_From_52_week_low="2.61"
change_in_percent="+2.77%"
close="4.08"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.11"
ebitda="-30.33M"
eps_estimate_current_year="-1.14"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.96"
ex_dividend_date="N/A"
float_shares="19694000"
high="4.19"
high_52_weeks="4.75"
last_trade_date="3/8/2017"
last_trade_price="4.08"
last_trade_size="630"
last_trade_time="4:00pm"
low="4.02"
low_52_weeks="1.47"
market_capitalization="139.32M"
moving_average_200_day="2.91"
moving_average_50_day="3.39"
name="Fate Therapeutics
Inc."
notes="N/A"
one_year_target_price="6.75"
open="4.05"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+40.17%"
percent_change_from_50_day_moving_average="+20.26%"
percent_change_from_52_week_high="-14.11%"
percent_change_from_52_week_low="+177.55%"
previous_close="3.97"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.34"
price_per_sales="30.46"
revenue="4.45M"
shares_outstanding="34148000"
short_ratio="2.29"
stock_exchange="NGM"
symbol="FATE"
volume="217969"
weeks_range_52="1.47 - 4.75"
